Related Experiment Video
Updated: Aug 9, 2026

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
Possible reduction in posttraumatic stress disorder symptoms with oxcarbazepine in a patient with bipolar disorder
Parviz Malek-Ahmadi1, Allan T Hanretta
1Department of Neuropsychiatry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA. parviz.malekahmadi@ttuhsc.edu
Objective:
To report the effect of oxcarbazepine in a patient with bipolar illness and posttraumatic stress disorder (PTSD).
Case Summary:
A 38-year-old white woman with PTSD and bipolar disorder who had partially responded to carbamazepine was treated with oxcarbazepine. Within a month of initiation of treatment with oxcarbazepine, she reported progressive improvement in her PTSD symptoms. As oxcarbazepine monotherapy with 750 mg twice daily continued, she reported significant reduction of her PTSD symptoms and stabilization of her mood. She tolerated oxcarbazepine without adverse effects.
Discussion:
PTSD symptoms tend to wax and wane. Spontaneous remission also occurs in some patients with PTSD. There are a few reports indicating that carbamazepine alleviates PTSD symptoms. Since oxcarbazepine is an analog of carbamazepine, it is theorized that oxcarbazepine also has efficacy in significantly reducing PTSD symptoms.
Conclusions:
There are case reports and uncontrolled studies suggesting that antiepileptic drugs (AEDs) alleviate PTSD symptoms. Oxcarbazepine may also benefit patients with PTSD. However, controlled studies are needed to investigate the use of AEDs in patients with PTSD and bipolar disorder.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Mania and Antimanic Drugs: Overview
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Bipolar Disorder
Drug Therapy
Antianxiety Medications
Electroconvulsive Therapy
